383 related articles for article (PubMed ID: 2052620)
1. p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia.
Gaidano G; Ballerini P; Gong JZ; Inghirami G; Neri A; Newcomb EW; Magrath IT; Knowles DM; Dalla-Favera R
Proc Natl Acad Sci U S A; 1991 Jun; 88(12):5413-7. PubMed ID: 2052620
[TBL] [Abstract][Full Text] [Related]
2. Analysis of RAS oncogene mutations in human lymphoid malignancies.
Neri A; Knowles DM; Greco A; McCormick F; Dalla-Favera R
Proc Natl Acad Sci U S A; 1988 Dec; 85(23):9268-72. PubMed ID: 3057505
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of p53 mutations in newly diagnosed Burkitt's lymphoma and acute lymphoblastic leukemia: a report of 48 cases.
Preudhomme C; Dervite I; Wattel E; Vanrumbeke M; Flactif M; Lai JL; Hecquet B; Coppin MC; Nelken B; Gosselin B
J Clin Oncol; 1995 Apr; 13(4):812-20. PubMed ID: 7707106
[TBL] [Abstract][Full Text] [Related]
4. Mutations of the p53 gene in B-cell lymphoblastic acute leukemia: a report on 60 cases.
Fenaux P; Jonveaux P; Quiquandon I; Preudhomme C; Lai JL; Vanrumbeke M; Loucheux-Lefebvre MH; Bauters F; Berger R; Kerckaert JP
Leukemia; 1992 Jan; 6(1):42-6. PubMed ID: 1736012
[TBL] [Abstract][Full Text] [Related]
5. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
Matolcsy A; Chadburn A; Knowles DM
Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
[TBL] [Abstract][Full Text] [Related]
6. Expression of A-myb, but not c-myb and B-myb, is restricted to Burkitt's lymphoma, sIg+ B-acute lymphoblastic leukemia, and a subset of chronic lymphocytic leukemias.
Golay J; Luppi M; Songia S; Palvarini C; Lombardi L; Aiello A; Delia D; Lam K; Crawford DH; Biondi A; Barbui T; Rambaldi A; Introna M
Blood; 1996 Mar; 87(5):1900-11. PubMed ID: 8634438
[TBL] [Abstract][Full Text] [Related]
7. Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis.
Lepelley P; Preudhomme C; Vanrumbeke M; Quesnel B; Cosson A; Fenaux P
Leukemia; 1994 Aug; 8(8):1342-9. PubMed ID: 8057671
[TBL] [Abstract][Full Text] [Related]
8. Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutations.
Cesarman E; Chadburn A; Inghirami G; Gaidano G; Knowles DM
Blood; 1992 Dec; 80(12):3205-16. PubMed ID: 1361372
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of p53 in 16 cases of acute lymphoblastic leukemia and Burkitt's lymphoma.
Nomdedéu JF; Lete I; Baiget M; Lasa A; Estivill C; Rubiol E; Badell I; Pardo N; Cubells J; Mateu R; Brunet S; Bordes R; Soler J
Haematologica; 1997; 82(5):550-4. PubMed ID: 9407719
[TBL] [Abstract][Full Text] [Related]
10. p53 mutation in B-cell lymphoid neoplasms with reference to oncogene rearrangements associated with chromosomal translocations.
Akasaka T; Muramatsu M; Kadowaki N; Ohno H; Ishizaki K; Yamabe H; Fukuhara S; Okuma M
Jpn J Cancer Res; 1996 Sep; 87(9):930-7. PubMed ID: 8878455
[TBL] [Abstract][Full Text] [Related]
11. Frequent p53 gene involvement in splenic B-cell leukemia/lymphomas of possible marginal zone origin.
Baldini L; Fracchiolla NS; Cro LM; Trecca D; Romitti L; Polli E; Maiolo AT; Neri A
Blood; 1994 Jul; 84(1):270-8. PubMed ID: 8018922
[TBL] [Abstract][Full Text] [Related]
12. G protein subunit G alpha 16 expression is restricted to progenitor B cells during human B-cell differentiation.
Mapara MY; Bommert K; Bargou RC; Leng C; Beck C; Ludwig WD; Gierschik P; Dörken B
Blood; 1995 Apr; 85(7):1836-42. PubMed ID: 7703490
[TBL] [Abstract][Full Text] [Related]
13. Hemi- or homozygosity: a requirement for some but not other p53 mutant proteins to accumulate and exert a pathogenetic effect.
Bhatia K; Goldschmidts W; Gutierrez M; Gaidano G; Dalla-Favera R; Magrath I
FASEB J; 1993 Jul; 7(10):951-6. PubMed ID: 8344493
[TBL] [Abstract][Full Text] [Related]
14. The pattern of p53 mutations in Burkitt's lymphoma differs from that of solid tumors.
Bhatia KG; Gutiérrez MI; Huppi K; Siwarski D; Magrath IT
Cancer Res; 1992 Aug; 52(15):4273-6. PubMed ID: 1638540
[TBL] [Abstract][Full Text] [Related]
15. Infrequent mutations in the P53 gene in primary human T-cell acute lymphoblastic leukemia.
Jonveaux P; Berger R
Leukemia; 1991 Oct; 5(10):839-40. PubMed ID: 1961018
[TBL] [Abstract][Full Text] [Related]
16. Richter's syndrome in a case of atypical chronic lymphocytic leukaemia with the t(11;14)(q13;q32): role for a p53 exon 7 gene mutation.
Cuneo A; de Angeli C; Roberti MG; Piva N; Bigoni R; Gandini D; Rigolin GM; Moretti S; Cavazzini P; del Senno L; Castoldi G
Br J Haematol; 1996 Feb; 92(2):375-81. PubMed ID: 8603003
[TBL] [Abstract][Full Text] [Related]
17. Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines.
Cheng J; Haas M
Mol Cell Biol; 1990 Oct; 10(10):5502-9. PubMed ID: 2144611
[TBL] [Abstract][Full Text] [Related]
18. FBXW7 mutation in adult T-cell and B-cell acute lymphocytic leukemias.
Song JH; Schnittke N; Zaat A; Walsh CS; Miller CW
Leuk Res; 2008 Nov; 32(11):1751-5. PubMed ID: 18485478
[TBL] [Abstract][Full Text] [Related]
19. Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemia.
Felix CA; Nau MM; Takahashi T; Mitsudomi T; Chiba I; Poplack DG; Reaman GH; Cole DE; Letterio JJ; Whang-Peng J
J Clin Invest; 1992 Feb; 89(2):640-7. PubMed ID: 1737852
[TBL] [Abstract][Full Text] [Related]
20. Mutation analysis of the FAS and TNFR apoptotic cascade genes in hematological malignancies.
Rozenfeld-Granot G; Toren A; Amariglio N; Brok-Simoni F; Rechavi G
Exp Hematol; 2001 Feb; 29(2):228-33. PubMed ID: 11166462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
